Clarkston Capital Partners’s Amgen AMGN Stock Holding History

Clarkston Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-646	Closed	-$211K	–	107
2025 Q4	$211K	Buy	+646	New	+$205K	﹤0.01%	171
2025 Q2	–	Sell	-646	Closed	-$201K	–	153
2025 Q1	$201K	Buy	+646	New	+$191K	﹤0.01%	145
2024 Q4	–	Sell	-646	Closed	-$208K	–	162
2024 Q3	$208K	Hold	646	–	–	﹤0.01%	140
2024 Q2	$202K	Buy	+646	New	+$190K	﹤0.01%	142
2024 Q1	–	Sell	-796	Closed	-$229K	–	156
2023 Q4	$229K	Buy	+796	New	+$217K	﹤0.01%	134
2020 Q1	–	Sell	-900	Closed	-$217K	–	105
2019 Q4	$217K	Buy	+900	New	+$198K	0.01%	95

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Clarkston Capital Partners's AMGN Position: Q1 2026 in Review

Clarkston Capital Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 646 shares — an estimated $211K sold.

Clarkston Capital Partners first reported a position in AMGN in Q4 2019 and held it in 6 quarters. The position peaked at $229K in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Clarkston Capital Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Clarkston Capital Partners sold 646 Amgen shares in Q1 2026, an estimated $211K.
Clarkston Capital Partners first reported a position in Amgen in Q4 2019 and held it in 6 quarters.
Clarkston Capital Partners's Amgen position peaked at $229K in Q4 2023.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Clarkston Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.